Successful treatment of severe cardiomyopathy in glycogen storage disease type III with d,l-3-hydroxybutyrate, ketogenic and high-protein diet

Pediatric Research

Volumn 70, Issue 6, 2011, Pages 638-641

  Valayannopoulos, Vassili ^a   Bajolle, Fanny ^b   Arnoux, Jean Baptiste ^a   Dubois, Sandrine ^a   Sannier, Nathalie ^d   Baussan, Christiane ^e   Petit, François ^f   Labrune, Philippe ^f   Rabier, Daniel ^c   Ottolenghi, Chris ^c   Vassault, Anne ^c   Broissand, Christine ^a   Bonnet, Damien ^b   De Lonlay, Pascale ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b Department of Pediatric Cardiology ^*  (France)

^c Metabolic Biochemistry Laboratory   (France)

^d Pediatrics Department   (France)

^e BICÊTRE HOSPITAL   (France)

^f HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; CREATINE KINASE; FATTY ACID; GLUCOSE; INSULIN; KETONE BODY; TRIACYLGLYCEROL;

ARTICLE; BODY GROWTH; CARDIOMYOPATHY; CASE REPORT; CONSANGUINITY; CREATINE KINASE BLOOD LEVEL; DRUG DOSE INCREASE; ECHOCARDIOGRAPHY; FAMILY HISTORY; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; GENE MUTATION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE INTAKE; GLYCOGEN STORAGE DISEASE; GLYCOGEN STORAGE DISEASE TYPE 3; HEPATOMEGALY; HUMAN; HYPERTRIGLYCERIDEMIA; HYPOGLYCEMIA; INFANT; KETOGENESIS; KETOGENIC DIET; LIPID DIET; LIVER SIZE; LOW CARBOHYDRATE DIET; MALE; PRIORITY JOURNAL; PROTEIN DIET; TRIACYLGLYCEROL BLOOD LEVEL;

3-HYDROXYBUTYRIC ACID; BLOOD GLUCOSE; CARDIOMYOPATHIES; CREATINE KINASE; DIETARY PROTEINS; GLYCOGEN STORAGE DISEASE TYPE III; HUMANS; INFANT; INSULIN; KETOGENIC DIET; KETONE BODIES; LIVER; MALE; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 80855156777     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e318232154f     Document Type: Article

References (14)

1. Smit GP, Fernandes J, Leonard JV, Matthews EE, Moses SW, Odievre M, Ullrich K 1990 The long-term outcome of patients with glycogen storage diseases. J Inherit Metab Dis 13:411-418 (Pubitemid 20374447)
2. Coleman RA, Winter HS, Wolf B, Gilchrist JM, Chen YT 1992 Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy. Ann Intern Med 116:896-900 (Pubitemid 23034780)
3. Momoi T, Sano H, Yamanaka C, Sasaki H, Mikawa H 1992 Glycogen storage disease type III with muscle involvement: reappraisal of phenotypic variability and prognosis. Am J Med Genet 42:696-699
4. Fernandes J, Leonard JV, Moses SW, Odievre M, di Rocco M, Schaub J, Smit GP, Ullrich K, Durand P 1988 Glycogen storage disease: recommendations for treatment. Eur J Pediatr 147:226-228
5. Akazawa H, Kuroda T, Kim S, Mito H, Kojo T, Shimada K 1997 Specific heart muscle disease associated with glycogen storage disease type III: clinical similarity to the dilated phase of hypertrophic cardiomyopathy. Eur Heart J 18:532-533 (Pubitemid 27110494)
6. Fiocchi F, Ricci C, Ligabue G, Reggianini L, Modena MG, Cenacchi G, Torricelli P 2008 Cardiac delayed enhancement distribution in extralysosomial glycogen storage disease. Clin Imaging 32:474-476
7. Van Hove JL, Grunewald S, Jaeken J, Demaerel P, Declercq PE, Bourdoux P, Niezen-Koning K, Deanfeld JE, Leonard JV 2003 D,L-3-hydroxybutyrate treatment of multiple acyl-CoA dehydrogenase deficiency (MADD). Lancet 361:1433-1435 (Pubitemid 36515046)
8. Balietti M, Fattoretti P, Giorgetti B, Casoli T, Di Stefano G, Solazzi M, Platano D, Aicardi G, Bertoni-Freddari C 2009 A ketogenic diet increases succinic dehydrogenase activity in aging cardiomyocytes. Ann N Y Acad Sci 1171:377-384
9. Zou Z, Sasaguri S, Rajesh KG, Suzuki R 2002 D,[SCAP]L-3-Hydroxybutyrate administration prevents myocardial damage after coronary occlusion in rat hearts. Am J Physiol Heart Circ Physiol 283:H1968-H1974 (Pubitemid 35217031)
10. Depre C, Hue L 1997 Inhibition of glycogenolysis by a glucose analogue in the working rat heart. J Mol Cell Cardiol 29:2253-2259 (Pubitemid 27348534)
11. Dagli AI, Zori RT, McCune H, Ivsic T, Maisenbacher MK, Weinstein DA 2009 Reversal of glycogen storage disease type IIIa-related cardiomyopathy with modification of diet. J Inherit Metab Dis DOI: 10.1007/s10545-009-1088-x
12. Slonim AE, Weisberg C, Benke P, Evans OB, Burr IM 1982 Reversal of debrancher deficiency myopathy by the use of high-protein nutrition. Ann Neurol 11:420-422 (Pubitemid 12133703)
13. Slonim AE, Coleman RA, Moses WS 1984 Myopathy and growth failure in debrancher enzyme deficiency: improvement with high-protein nocturnal enteral therapy. J Pediatr 105:906-911 (Pubitemid 15185316)
14. Dai YJ, Chen L, Guo YP, Ren HT, Zhao YH, Wei M, Qiu ZQ, Song HM 2009 [Clinical and pathological features of glycogen storage disease type III]. Zhonghua Yi Xue Za Zhi 89:1064-1066